Search
for
Sort by
Research 781–810 of 1000+
- Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
- Menopause and hair loss in women: Exploring the hormonal transition
- Association of Acne Tarda with Endocrinological Disorders
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
- Rare virilizing tumor: ovarian steroid cell tumor, not otherwise specified: a case report
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Polycystic Ovary Syndrome and Oxidative Stress—From Bench to Bedside
- Hyaluronic Acid Profhilo® Alleviates Skin Inflammation and Spinal Neuroimmune Alterations in a Mouse Model of Atopic Dermatitis
- Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations
- Nutritional Disorders of the Hair and Their Management
- How Biotin Induces Misleading Results in Thyroid Bioassays: Case Series
- Ernährungsstörungen des Haares und deren Management
- Transcription factor-based transdifferentiation of human embryonic to trophoblast stem cells
- From bench to babies – drug development for male subfertility
- Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy
- Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial
- Multidisciplinary screening and diagnosis of obesity related diseases: an Arabic Association for the Study of Diabetes and metabolism position statement (AASD)
- Clinical and Hormonal Effects of Chronic Gonadotropin Releasing Hormone Agonist Treatment in Polycystic Ovarian Disease*
- Treatment of Hirsutism with a Gonadotropin-Releasing Hormone Agonist (Nafarelin)∗
- Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism.
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Gonadotropin-Releasing Hormone Agonist Treatment in Postmenopausal Women with Hyperandrogenism of Ovarian Origin
- Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys--a clinical research center study.
- Long-Term Suppression of Testosterone After Treatment with a Gonadotropin-Releasing Hormone Agonist in a Woman with a Presumed Testosterone Secreting Ovarian Tumor
- Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy
- A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism.
- Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
- (PNM-35) Recurrent priapism in a sickle cell disease patient treated with gonadotropin-releasing hormone (GnRH) agonists drugs: a case report
- A Novel Nomogram for Predicting Gonadotropin-Releasing Hormone Analogue Treatment Outcome in Girls with Idiopathic Central Precocious Puberty
- Dienogest versus gonadotropin-releasing hormone analogues for the clinical treatment of endometriosis: an updated meta-analysis